Cognitive Functions in Repeated Glioma Surgery.
awake surgery
diffuse low surgery
neurocognition
neuropsychological assessment
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
26 Apr 2020
26 Apr 2020
Historique:
received:
13
04
2020
accepted:
21
04
2020
entrez:
3
5
2020
pubmed:
3
5
2020
medline:
3
5
2020
Statut:
epublish
Résumé
Low-grade gliomas (LGG) are slow-growing brain tumors infiltrating the central nervous system which tend to recur, often with malignant degeneration after primary treatment. Re-operations are not always recommended due to an assumed higher risk of neurological and cognitive deficits. However, this assumption is relatively ungrounded due to a lack of extensive neuropsychological testing. We retrospectively examined a series of 40 patients with recurrent glioma in eloquent areas of the left hemisphere, who all completed comprehensive pre- (T3) and post-surgical (T4) neuropsychological assessments after a second surgery (4-month follow up). The lesions were most frequent in the left insular cortex and the inferior frontal gyrus. Among this series, in 17 patients the cognitive outcomes were compared before the first surgery (T1), 4 months after the first surgery (T2), and at T3 and T4. There was no significant difference either in the number of patients scoring within the normal range between T3 and T4, or in their level of performance. Further addressing the T1-T4 evolution, there was no significant difference in the number of patients scoring within the normal range. As to their level of performance, the only significant change was in phonological fluency. This longitudinal follow-up study showed that repeated glioma surgery is possible without major damage to cognitive functions in the short-term period (4 months) after surgery.
Identifiants
pubmed: 32357421
pii: cancers12051077
doi: 10.3390/cancers12051077
pmc: PMC7281009
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
World Neurosurg. 2017 Jul;103:799-808.e9
pubmed: 28411105
Biomed Res Int. 2015;2015:497610
pubmed: 26539503
Acta Neurochir (Wien). 2016 Jan;158(1):51-8
pubmed: 26530708
J Neurooncol. 2013 Jun;113(2):267-75
pubmed: 23479036
Neurosurgery. 2012 May;70(5):1081-93; discussion 1093-4
pubmed: 22067417
J Neurosurg. 1989 Sep;71(3):316-26
pubmed: 2769383
Neurol Sci. 2015 Feb;36(2):345-7
pubmed: 25491661
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):901-7
pubmed: 12810776
J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):845-51
pubmed: 15897509
Neurosurgery. 2008 Oct;63(4):700-7; author reply 707-8
pubmed: 18981880
Ann Oncol. 2008 Sep;19 Suppl 7:vii217-22
pubmed: 18790954
J Clin Neurosci. 2006 Nov;13(9):885-97
pubmed: 17049865
Neurosurgery. 2015 Aug;77(2):175-84; discussion 184
pubmed: 25850601
J Neurosurg. 2003 Jun;98(6):1165-9
pubmed: 12816258
J Neurooncol. 2019 Sep;144(3):519-528
pubmed: 31363908
Cortex. 1978 Mar;14(1):41-9
pubmed: 16295108
Clin Neurosurg. 1994;41:444-63
pubmed: 7842620
Cancer. 2004 Jun 15;100(12):2622-6
pubmed: 15197805
Acta Neurochir (Wien). 2009 May;151(5):427-36; discussion 436
pubmed: 19337688
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):965-971
pubmed: 29485076
Stereotact Funct Neurosurg. 1992;58(1-4):153-61
pubmed: 1439333
J Clin Oncol. 2008 Mar 10;26(8):1338-45
pubmed: 18323558
Ital J Neurol Sci. 1987 Dec;Suppl 8:1-120
pubmed: 3330072
Clin Neurol Neurosurg. 2016 Dec;151:18-23
pubmed: 27736650
J Neurooncol. 2011 Aug;104(1):253-9
pubmed: 21153680
Acta Neurol Belg. 2017 Mar;117(1):235-239
pubmed: 27271289
J Neurosurg. 2016 Oct;125(4):877-887
pubmed: 26848912
J Neurosurg. 2012 Dec;117(6):1039-52
pubmed: 23039150
Neurol Sci. 2013 May;34(5):749-54
pubmed: 22689311
World Neurosurg. 2019 Aug;128:e21-e30
pubmed: 30880199
Lancet Neurol. 2005 Aug;4(8):476-86
pubmed: 16033690
J Neurosurg. 2019 Dec 27;:1-9
pubmed: 31881532
Neurosurgery. 2019 Oct 1;85(4):E641-E649
pubmed: 31069381
J Neurooncol. 2012 Jan;106(2):353-66
pubmed: 21785913
Neuro Oncol. 2009 Aug;11(4):437-45
pubmed: 19018039
J Neurooncol. 2012 Dec;110(3):325-33
pubmed: 23015095
J Neurooncol. 2017 Jun;133(2):309-313
pubmed: 28560660
J Neurosurg Sci. 2020 Feb 04;:
pubmed: 32031360
Acta Neurochir (Wien). 2009 Nov;151(11):1359-65
pubmed: 19575144
Can J Surg. 1993 Jun;36(3):271-5
pubmed: 8391917
Neuropsychologia. 1971 Mar;9(1):97-113
pubmed: 5146491
Arch Neurol. 1980 Jan;37(1):6-10
pubmed: 7350907
Neuro Oncol. 2015 Mar;17(3):332-42
pubmed: 25087230
Eur Radiol. 2019 Jun;29(6):2751-2759
pubmed: 30617484
Brain. 2007 Apr;130(Pt 4):898-914
pubmed: 17121742
Neurosurgery. 1987 Nov;21(5):615-21
pubmed: 2827052
JAMA. 2012 Nov 14;308(18):1881-8
pubmed: 23099483
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
PLoS One. 2017 Aug 1;12(8):e0179999
pubmed: 28763450
Cancer. 2012 Jan 15;118(2):452-60
pubmed: 21717448
Adv Tech Stand Neurosurg. 2008;33:3-33
pubmed: 18383811
J Neurosurg. 2016 May;124(5):1460-9
pubmed: 26544767